Achyut Saroj, Founder, Consultant, and Author at AwareOnc, KOL Engagement and Medical Affairs Liaison at Tatva Health, shared a post on LinkedIn:
“Understanding Cancer Risk After Organ Transplantation
A groundbreaking study published today in JAMA Oncology provides critical insights for the transplant and oncology communities regarding patients with a history of cancer before receiving a solid organ transplant (SOT).
While it is well-known that transplant recipients face an elevated risk of cancer due to immunosuppression, this study, one of the largest of its kind, analyzed data from over 520,000 SOT recipients to identify specific patterns of risk for cancer survivors.
- Same-Site Risk: Recipients with a pretransplant cancer history have a significantly elevated risk of developing the same type of cancer posttransplant. This was particularly evident for cancers of the breast, lung, kidney, liver, colorectum, urinary bladder, and melanoma.
- Cross-Type Associations: The research also identified significant links between different cancer types, such as pretransplant liver cancer being associated with an increased risk of posttransplant lung and prostate cancers.
- Melanoma Risk: The association was strongest for melanoma, with an incidence rate ratio (IRR) of 10.4 for those with a pretransplant history of the disease.
Why This Matters:
These findings suggest that ‘one size fits all’ screening may not be enough. The study authors emphasize that SOT recipients who are also cancer survivors may require targeted, organ-specific screening and enhanced monitoring to catch subsequent cancers early.
As we continue to improve long-term outcomes for transplant recipients, integrating these risk patterns into clinical practice will be essential for personalized posttransplant care.”
Title: Cancer Risk in Solid Organ Transplant Recipients With a Pretransplant Cancer History
Authors: Jun Tao, Ruth M. Pfeiffer, Shyfuddin Ahmed, Qianlai Luo, Baozhen Qiao, Charles F. Lynch, Tabassum Insaf, Daniela Ramirez-Aguilar, Ajay Israni, Lindsay M. Morton, Eric A. Engels
Read the Full Article.
Other articles featuring Achyut Saroj on OncoDaily.